Asthma
Dangers of SABA Overuse
Find out the risks associated with overreliance on SABA and explore treatment alternatives and strategies based on the latest recommendations.
The Global Initiative for Asthma (GINA) no longer recommends SABA-only treatment. In the stepwise approach to asthma management, Track 1 emphasizes ICS-formoterol as the preferred reliever and controller, effectively managing symptoms and reducing exacerbations.
Asthma Still Kills!
Let’s delve into the reality of asthma as a chronic inflammatory disease and the pressing need to improve treatment strategies for better outcomes.
In the Philippines, inadequate asthma management persists, contributing to high mortality rates and frequent exacerbations.
This video highlights the nature of asthma as a chronic inflammatory disease and the challenges we face in optimizing treatment for better patient outcomes.
Unlock the power of Anti-Inflammatory Reliever (AIR) in asthma.
Explore GINA’s stepwise approach to chronic asthma, advocating AIR for effective symptom control and reduction in exacerbation.
GINA’s Global Strategy on Asthma Management recommends two treatment tracks for optimized asthma management and improved overall patient outcomes. Learn about the evidence surrounding the recommendation.
Empowered Asthma Control
Discover vital strategies for achieving asthma control and empower your patients with effective action plans. Join the journey by watching this video!
Gain insights into the pivotal role of a collaborative patient-physician partnership and explore how patient education and action plans contribute to better asthma control.